Quantum BioPharma Ltd. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
Quantum BioPharma Ltd. (QNTM) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of $18.60 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2026-03-26
- Quantum BioPharma Ltd. weighted average exercise price of share options granted in share-based payment arrangement2019 for the quarter ending 2025-03-31 was $9.46, a 90.30% decline year-over-year.
- Quantum BioPharma Ltd. weighted average exercise price of share options granted in share-based payment arrangement2019 for the quarter ending 2024-03-31 was $97.50.
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 3 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|---|
| 2025-12-31 | $18.60 20-F · filed 2026-03-26 | |
| 2025-03-31 | $9.46 6-K/A · filed 2025-06-16 | |
| 2024-12-31 | $26.24 20-F · filed 2026-03-26 | |
| 2024-03-31 | $97.50 6-K/A · filed 2025-06-16 | |
| 2023-12-31 | $99.05 20-F · filed 2026-03-26 |
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 9 month |
|---|---|---|
| 2025-09-30 | 18.60 CAD/shares 6-K · filed 2025-11-06 | |
| 2025-06-30 | 9.90 CAD/shares 6-K · filed 2025-08-07 | |
| 2024-09-30 | 26.24 CAD/shares 6-K · filed 2025-11-06 | |
| 2024-06-30 | 97.50 CAD/shares 6-K · filed 2025-08-07 |